Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-11

Clinical Trial Update: A Protected Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants and Children [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy of an inactivated EV71 vaccine (KMB-17) for preventing hand, foot, and mouth disease in Chinese infants and childre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) (EV71 vaccine)

Snippet

Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences | Conditions: The Efficacy of Inactivated EV71 Vaccine (KMB17) Against HFMD in Chinese Children and Infants | Phase 3 | Status: COMPLETED